凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CASI 凯信远达

盘后交易 07-17 17:38:20 EDT

6.29

-0.07

-1.18%

盘后6.29

+0.00+0.08%

16:00 EDT

最高6.38	最低6.05	成交量2.17万
今开6.17	昨收6.36	日振幅5.19%
总市值8,423万	流通市值3,887万	总股本1,340万
成交额13.47万	换手率0.35%	流通股本618.45万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CASI","market":"US","secType":"STK","nameCN":"凯信远达","latestPrice":6.285,"timestamp":1721246400000,"preClose":6.36,"halted":0,"volume":21691,"hourTrading":{"tag":"盘后","latestPrice":6.29,"preClose":6.285,"latestTime":"16:00 EDT","volume":78,"amount":490.62,"timestamp":1721246401976},"delay":0,"floatShares":6184500,"shares":13401375,"eps":-2.279577,"marketStatus":"盘后交易","marketStatusCode":4,"change":-0.075,"latestTime":"07-17 17:38:20 EDT","open":6.17,"high":6.38,"low":6.05,"amount":134743.494214,"amplitude":0.051887,"askPrice":6.46,"askSize":50,"bidPrice":6.13,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-2.279577,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1721260800000},"adr":0,"listingDate":834552000000,"adjPreClose":6.36,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":6.22,"preClose":6.2,"latestTime":"09:27 EDT","volume":239,"amount":1480.519916,"timestamp":1721222870132},"postHourTrading":{"tag":"盘后","latestPrice":6.29,"preClose":6.285,"latestTime":"16:00 EDT","volume":78,"amount":490.62,"timestamp":1721246401976},"volumeRatio":0.261733,"impliedVol":0.7344,"impliedVolPercentile":0.119},"requestUrl":"/m/hq/s/CASI/tweets","defaultTab":"tweets","newsList":[{"id":"2451691186","title":"凯信远达下跌5.33%，报5.917美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451691186","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451691186?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:15","pubTimestamp":1721142942,"startTime":"0","endTime":"0","summary":"7月16日，凯信远达(CASI)盘中下跌5.33%，截至23:15，报5.917美元/股，成交11.25万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/16231541608575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2451192259","title":"凯信远达盘中异动 早盘股价大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451192259","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451192259?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:15","pubTimestamp":1721142922,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时15分，凯信远达股票出现异动，股价急速下跌5.33%。截至发稿，该股报5.92美元/股，成交量1.7695万股，换手率0.13%，振幅7.04%。凯信远达股票所在的生物技术行业中，整体涨幅为0.34%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231522941f779c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231522941f779c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2451252306","title":"凯信远达上涨3.53%，报6.45美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451252306","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451252306?lang=zh_cn&edition=full","pubTime":"2024-07-15 22:12","pubTimestamp":1721052763,"startTime":"0","endTime":"0","summary":"7月15日，凯信远达(CASI)盘中上涨3.53%，截至22:12，报6.45美元/股，成交6.41万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/15221241584195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2451236376","title":"凯信远达盘中异动 股价大涨6.74%报6.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451236376","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451236376?lang=zh_cn&edition=full","pubTime":"2024-07-15 21:35","pubTimestamp":1721050520,"startTime":"0","endTime":"0","summary":"北京时间2024年07月15日21时35分，凯信远达股票出现异动，股价快速上涨6.74%。截至发稿，该股报6.65美元/股，成交量703股，换手率0.01%，振幅2.09%。凯信远达股票所在的生物技术行业中，整体跌幅为0.14%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152135209681ccf3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407152135209681ccf3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2450636062","title":"凯信远达下跌6.75%，报6.08美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450636062","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450636062?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:53","pubTimestamp":1720713210,"startTime":"0","endTime":"0","summary":"7月11日，凯信远达(CASI)盘中下跌6.75%，截至23:53，报6.08美元/股，成交14.33万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/11235341527312.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2450367068","title":"凯信远达盘中异动 股价大跌6.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450367068","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450367068?lang=zh_cn&edition=full","pubTime":"2024-07-11 23:53","pubTimestamp":1720713205,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日23时53分，凯信远达股票出现波动，股价急速下跌6.75%。截至发稿，该股报6.08美元/股，成交量2.0915万股，换手率0.16%，振幅3.99%。凯信远达股票所在的生物技术行业中，整体涨幅为0.53%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112353269681c0ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407112353269681c0ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2450816663","title":"凯信远达盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450816663","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450816663?lang=zh_cn&edition=full","pubTime":"2024-07-10 22:18","pubTimestamp":1720621128,"startTime":"0","endTime":"0","summary":"北京时间2024年07月10日22时18分，凯信远达股票出现异动，股价大幅下挫5.56%。截至发稿，该股报6.46美元/股，成交量2.0009万股，换手率0.15%，振幅4.82%。凯信远达股票所在的生物技术行业中，整体涨幅为0.30%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710221849941f5d88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710221849941f5d88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2450024566","title":"凯信远达盘中异动 急速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450024566","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450024566?lang=zh_cn&edition=full","pubTime":"2024-07-09 23:04","pubTimestamp":1720537455,"startTime":"0","endTime":"0","summary":"北京时间2024年07月09日23时04分，凯信远达股票出现异动，股价快速拉升5.22%。截至发稿，该股报6.85美元/股，成交量3.3968万股，换手率0.25%，振幅7.22%。凯信远达股票所在的生物技术行业中，整体跌幅为0.54%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709230415941f5756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240709230415941f5756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2450029141","title":"凯信远达上涨2.92%，报6.7美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450029141","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450029141?lang=zh_cn&edition=full","pubTime":"2024-07-09 22:52","pubTimestamp":1720536728,"startTime":"0","endTime":"0","summary":"7月9日，凯信远达(CASI)盘中上涨2.92%，截至22:52，报6.7美元/股，成交15.07万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/09225241470824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2449701371","title":"凯信远达盘中异动 快速上涨6.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449701371","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449701371?lang=zh_cn&edition=full","pubTime":"2024-07-08 22:28","pubTimestamp":1720448938,"startTime":"0","endTime":"0","summary":"北京时间2024年07月08日22时28分，凯信远达股票出现波动，股价大幅上涨6.45%。截至发稿，该股报6.10美元/股，成交量3.5981万股，换手率0.27%，振幅5.58%。凯信远达股票所在的生物技术行业中，整体涨幅为0.83%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222858aef87aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240708222858aef87aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2449706638","title":"凯信远达上涨2.27%，报5.86美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449706638","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449706638?lang=zh_cn&edition=full","pubTime":"2024-07-08 21:53","pubTimestamp":1720446790,"startTime":"0","endTime":"0","summary":"7月8日，凯信远达(CASI)盘中上涨2.27%，截至21:53，报5.86美元/股，成交10.78万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/08215341444795.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2449292446","title":"凯信远达盘中异动 股价大涨5.36%报5.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2449292446","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449292446?lang=zh_cn&edition=full","pubTime":"2024-07-06 00:12","pubTimestamp":1720195959,"startTime":"0","endTime":"0","summary":"北京时间2024年07月06日00时12分，凯信远达股票出现异动，股价急速上涨5.36%。截至发稿，该股报5.53美元/股，成交量4.4731万股，换手率0.33%，振幅4.76%。凯信远达股票所在的生物技术行业中，整体涨幅为1.56%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706001239941f47a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240706001239941f47a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2449506298","title":"凯信远达上涨3.05%，报5.41美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2449506298","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449506298?lang=zh_cn&edition=full","pubTime":"2024-07-05 21:46","pubTimestamp":1720187204,"startTime":"0","endTime":"0","summary":"7月5日，凯信远达(CASI)盘中上涨3.05%，截至21:46，报5.41美元/股，成交6.21万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/05214641410549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2448848597","title":"凯信远达盘中异动 急速下跌5.64%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448848597","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448848597?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:59","pubTimestamp":1720015142,"startTime":"0","endTime":"0","summary":"北京时间2024年07月03日21时59分，凯信远达股票出现波动，股价快速下跌5.64%。截至发稿，该股报5.11美元/股，成交量4713股，换手率0.04%，振幅4.44%。凯信远达股票所在的生物技术行业中，整体跌幅为0.78%。凯信远达公司简介：CASI Pharmaceuticals Inc是一家生物制药公司，致力于将创新疗法和药物产品商业化。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215902941f385b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703215902941f385b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2448488048","title":"凯信远达下跌2.96%，报5.25美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448488048","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448488048?lang=zh_cn&edition=full","pubTime":"2024-07-03 21:41","pubTimestamp":1720014086,"startTime":"0","endTime":"0","summary":"7月3日，凯信远达(CASI)盘中下跌2.96%，截至21:41，报5.25美元/股，成交1.58万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/03214141360683.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2448152624","title":"凯信远达盘中异动 早盘股价大跌5.56%报5.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448152624","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448152624?lang=zh_cn&edition=full","pubTime":"2024-07-02 21:33","pubTimestamp":1719927183,"startTime":"0","endTime":"0","summary":"北京时间2024年07月02日21时33分，凯信远达股票出现波动，股价急速下挫5.56%。截至发稿，该股报5.10美元/股，成交量1.2197万股，换手率0.09%，振幅1.85%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体跌幅为0.62%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022133039566ca37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407022133039566ca37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0},{"id":"2448945354","title":"凯信远达上涨2.55%，报5.64美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448945354","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448945354?lang=zh_cn&edition=full","pubTime":"2024-07-02 01:18","pubTimestamp":1719854328,"startTime":"0","endTime":"0","summary":"7月2日，凯信远达(CASI)盘中上涨2.55%，截至01:18，报5.64美元/股，成交71.58万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/07/02011841311438.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2448691342","title":"凯信远达盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448691342","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448691342?lang=zh_cn&edition=full","pubTime":"2024-07-01 21:49","pubTimestamp":1719841792,"startTime":"0","endTime":"0","summary":"北京时间2024年07月01日21时49分，凯信远达股票出现波动，股价大幅跳水5.09%。截至发稿，该股报5.22美元/股，成交量2.3314万股，换手率0.17%，振幅3.57%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.76%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214952968186f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240701214952968186f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2446968415","title":"凯信远达上涨2.04%，报5.0美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446968415","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446968415?lang=zh_cn&edition=full","pubTime":"2024-06-28 23:08","pubTimestamp":1719587297,"startTime":"0","endTime":"0","summary":"6月28日，凯信远达(CASI)盘中上涨2.04%，截至23:08，报5.0美元/股，成交102.91万美元。财务数据显示，截至2024年03月31日，凯信远达收入总额340.9万美元，同比减少59.16%；归母净利润-952.8万美元，同比减少58.56%。大事提醒：8月9日，凯信远达将披露2024财年中报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/06/28230841275467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","CASI"],"gpt_icon":0},{"id":"2446745688","title":"凯信远达盘中异动 早盘股价大跌5.10%报4.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446745688","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446745688?lang=zh_cn&edition=full","pubTime":"2024-06-28 21:43","pubTimestamp":1719582198,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日21时43分，凯信远达股票出现异动，股价急速下跌5.10%。截至发稿，该股报4.65美元/股，成交量7.3915万股，换手率0.55%，振幅3.26%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。凯信远达股票所在的生物技术行业中，整体涨幅为0.01%。该产品包括针对患有白血病和淋巴瘤的患者的注射剂。EVOMELA注射液用于多发性骨髓瘤患者自体干细胞移植前作为条件治疗。大部分收入来自EVOMELA的产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214319aef72945&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628214319aef72945&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CASI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.casipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0702},{"period":"1month","weight":1.045},{"period":"3month","weight":1.8393},{"period":"6month","weight":0.2619},{"period":"1year","weight":1.4},{"period":"ytd","weight":-0.1117}],"compareEarnings":[{"period":"1week","weight":0.0163},{"period":"1month","weight":0.0407},{"period":"3month","weight":0.1285},{"period":"6month","weight":0.1855},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.1884}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"凯信远达医药公司于1991年注册成立，是一家在开曼群岛注册成立的豁免公司。该公司是一家生物制药公司，专注于在中国、美国和世界各地开发和商业化创新疗法和医药产品。公司打造了一家完全一体化、世界一流的生物制药公司，致力于创新和其他治疗产品的成功开发和商业化。公司业务发展战略目前的重点是通过许可获得额外的靶向药物和免疫肿瘤疗法，这将扩大血液学/肿瘤学特许经营权。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.175785},{"month":2,"riseRate":0.357143,"avgChangeRate":-0.007195},{"month":3,"riseRate":0.321429,"avgChangeRate":0.000453},{"month":4,"riseRate":0.392857,"avgChangeRate":0.035566},{"month":5,"riseRate":0.25,"avgChangeRate":0.051764},{"month":6,"riseRate":0.444444,"avgChangeRate":-0.0196},{"month":7,"riseRate":0.241379,"avgChangeRate":-0.066603},{"month":8,"riseRate":0.321429,"avgChangeRate":-0.028621},{"month":9,"riseRate":0.5,"avgChangeRate":0.010846},{"month":10,"riseRate":0.642857,"avgChangeRate":0.100523},{"month":11,"riseRate":0.392857,"avgChangeRate":0.045763},{"month":12,"riseRate":0.25,"avgChangeRate":-0.092857}],"exchange":"NASDAQ","name":"凯信远达","nameEN":"CASI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯信远达,CASI,凯信远达股票,凯信远达股票老虎,凯信远达股票老虎国际,凯信远达行情,凯信远达股票行情,凯信远达股价,凯信远达股市,凯信远达股票价格,凯信远达股票交易,凯信远达股票购买,凯信远达股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯信远达(CASI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯信远达(CASI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}